Becton, Dickinson and Company Board Declares Dividend, Payable on March 30, 2018
January 23, 2018 at 03:00 am IST
Share
The Board of Directors of BD has declared a quarterly dividend of $0.75 per common share, payable on March 30, 2018 to holders of record on March 9, 2018. The indicated annual dividend rate is $3.00 per share. In addition, the Board of Directors has declared a quarterly dividend of $15.3125 per share on the 6.125% mandatory convertible preferred stock, Series A, payable on May 1, 2018 to holders of record on April 13, 2018. This represents $0.7656 per depositary share.
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:
- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;
- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;
- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.
Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
BECTON, DICKINSON AND COMPANY 
